Correlation Between ATyr Pharma and ATAI Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and ATAI Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and ATAI Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and ATAI Life Sciences, you can compare the effects of market volatilities on ATyr Pharma and ATAI Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of ATAI Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and ATAI Life.

Diversification Opportunities for ATyr Pharma and ATAI Life

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between ATyr and ATAI is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and ATAI Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATAI Life Sciences and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with ATAI Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATAI Life Sciences has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and ATAI Life go up and down completely randomly.

Pair Corralation between ATyr Pharma and ATAI Life

Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the ATAI Life. In addition to that, ATyr Pharma is 2.3 times more volatile than ATAI Life Sciences. It trades about -0.07 of its total potential returns per unit of risk. ATAI Life Sciences is currently generating about 0.0 per unit of volatility. If you would invest  174.00  in ATAI Life Sciences on October 2, 2024 and sell it today you would lose (40.00) from holding ATAI Life Sciences or give up 22.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy38.86%
ValuesDaily Returns

ATyr Pharma  vs.  ATAI Life Sciences

 Performance 
       Timeline  
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
ATAI Life Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ATAI Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, ATAI Life demonstrated solid returns over the last few months and may actually be approaching a breakup point.

ATyr Pharma and ATAI Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATyr Pharma and ATAI Life

The main advantage of trading using opposite ATyr Pharma and ATAI Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, ATAI Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATAI Life will offset losses from the drop in ATAI Life's long position.
The idea behind ATyr Pharma and ATAI Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.